1. Home
  2. GEMI vs PHAR Comparison

GEMI vs PHAR Comparison

Compare GEMI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

N/A

Current Price

$7.51

Market Cap

1.2B

Sector

N/A

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$15.52

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEMI
PHAR
Founded
2014
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
GEMI
PHAR
Price
$7.51
$15.52
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$20.00
$38.00
AVG Volume (30 Days)
1.5M
37.7K
Earning Date
11-14-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
$162,529,000.00
$362,274,000.00
Revenue This Year
$20.81
$25.19
Revenue Next Year
$79.83
$4.47
P/E Ratio
N/A
$2,833.20
Revenue Growth
65.61
26.78
52 Week Low
$6.47
$7.50
52 Week High
$45.89
$21.34

Technical Indicators

Market Signals
Indicator
GEMI
PHAR
Relative Strength Index (RSI) 34.44 36.80
Support Level $6.47 $15.26
Resistance Level $8.05 $16.48
Average True Range (ATR) 0.65 0.66
MACD -0.06 -0.43
Stochastic Oscillator 17.38 4.27

Price Performance

Historical Comparison
GEMI
PHAR

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: